ClinicalTrials.Veeva

Menu

Diabetes, Falls, and Fractures (DIAFALL)

A

Aalborg University Hospital

Status

Completed

Conditions

Balance; Distorted
Diabetes
Muscle Weakness
Vestibular Neuropathy
Small Fiber Neuropathy
Sarcopenia
Autonomic Neuropathy, Diabetic
Diabetic Peripheral Neuropathy

Treatments

Diagnostic Test: Accelerometer
Diagnostic Test: Video Head Impulse Test
Diagnostic Test: Composite Autonomic Symptom Score 31
Diagnostic Test: Quantative Sensory Testing
Diagnostic Test: Computerized dynamic posturography
Diagnostic Test: Handgrip strength
Diagnostic Test: Dual Energy X-ray Absorbtimetry scan
Diagnostic Test: NCStat-DPN-Check
Diagnostic Test: Force Plate Platform

Study type

Observational

Funder types

Other

Identifiers

NCT05389566
N-20190004

Details and patient eligibility

About

Comparing severity of diabetic peripheral neuropathy (small and large fibers including autonomic neuroapthy) to postural control and vestibular measurements

Enrollment

110 patients

Sex

All

Ages

40 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Men and women with minimum 40 years of age and maximum 70 years of age.
  2. Diagnosis of T1D or T2D
  3. Diagnosis of diabetes with at least one year prior to inclusion of the study
  4. Signed the informed consent.

Exclusion criteria

  1. Severe decreased liver function (Alanin amino-transaminase (ALAT)>250u/l, GammaGlutamyltransferase (GGT)>150u/l)

  2. Moderate to severe kidney dysfunction, estimated Glomerular Filtration Rate (eGFR) <15mmol/L/1,73m2

  3. Pregnancy or breast feeding

  4. Active malignancy or terminal ill.

  5. Current or previous alcohol- or drug abuse

  6. Not being able to understand Danish written and/or verbally 9. Terms according to investigators judgement that makes subjects unsuitable to participate including lack of understanding or reduced physical ability. 10. Participating in other clinical studies 11. Maximum of 10 hours of weekly exercise.

Trial design

110 participants in 3 patient groups

Type 1 diabetes
Description:
People with type 1 diabetes above 40 years
Treatment:
Diagnostic Test: Force Plate Platform
Diagnostic Test: NCStat-DPN-Check
Diagnostic Test: Dual Energy X-ray Absorbtimetry scan
Diagnostic Test: Handgrip strength
Diagnostic Test: Computerized dynamic posturography
Diagnostic Test: Quantative Sensory Testing
Diagnostic Test: Composite Autonomic Symptom Score 31
Diagnostic Test: Accelerometer
Diagnostic Test: Video Head Impulse Test
People with type 2 diabetes
Description:
People with type 2 diabetes above 50 years
Treatment:
Diagnostic Test: Force Plate Platform
Diagnostic Test: NCStat-DPN-Check
Diagnostic Test: Dual Energy X-ray Absorbtimetry scan
Diagnostic Test: Handgrip strength
Diagnostic Test: Computerized dynamic posturography
Diagnostic Test: Quantative Sensory Testing
Diagnostic Test: Composite Autonomic Symptom Score 31
Diagnostic Test: Accelerometer
Diagnostic Test: Video Head Impulse Test
Healthy controls
Description:
Healthy controls without diabetes
Treatment:
Diagnostic Test: Force Plate Platform
Diagnostic Test: NCStat-DPN-Check
Diagnostic Test: Dual Energy X-ray Absorbtimetry scan
Diagnostic Test: Handgrip strength
Diagnostic Test: Computerized dynamic posturography
Diagnostic Test: Quantative Sensory Testing
Diagnostic Test: Composite Autonomic Symptom Score 31
Diagnostic Test: Accelerometer
Diagnostic Test: Video Head Impulse Test

Trial contacts and locations

1

Loading...

Central trial contact

Nicklas H Rasmussen, PhD; Peter Vestergaard, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems